Search research articles
Contact Us
Filters
Showing results (211-220 of 337) with videos related to
Page
of 34
Sort By:
BMC Infectious Diseases
|
January 29, 2021
Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy - a case report
Kai Rejeski, Wolfgang G Kunz, Martina Rudelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Improvement of overall survival in advanced stage mantle cell lymphoma
Annina Herrmann, Eva Hoster, Thomas Zwingers, et al.
Hemasphere
|
October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
Mats Jerkeman, Igor Aurer, Elias Campo, et al.
Annals of Hematology
|
August 8, 2023
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis
Luca Fischer, Linmiao Jiang, Joerg Thomas Bittenbring, et al.
Leukemia
|
September 16, 2024
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
Mouhamad Khouja, Linmiao Jiang, Karol Pal, et al.
Haematologica
|
January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.
Blood
|
May 30, 2015
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Marie-Hélène Delfau-Larue, Wolfram Klapper, Françoise Berger, et al.
British Journal of Haematology
|
August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
Hilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group
Wolfram Klapper, Eva Hoster, Lars Rölver, et al.
Blood Advances
|
April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Diego Villa, Eva Hoster, Olivier Hermine, et al.
Page
of 34
Search research articles
Search
Showing results (211-220 of 337) with videos related to
Sort By:
Page
of 34
BMC Infectious Diseases
|
January 29, 2021
Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy - a case report
Kai Rejeski, Wolfgang G Kunz, Martina Rudelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Improvement of overall survival in advanced stage mantle cell lymphoma
Annina Herrmann, Eva Hoster, Thomas Zwingers, et al.
Hemasphere
|
October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
Mats Jerkeman, Igor Aurer, Elias Campo, et al.
Annals of Hematology
|
August 8, 2023
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis
Luca Fischer, Linmiao Jiang, Joerg Thomas Bittenbring, et al.
Leukemia
|
September 16, 2024
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
Mouhamad Khouja, Linmiao Jiang, Karol Pal, et al.
Haematologica
|
January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.
Blood
|
May 30, 2015
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Marie-Hélène Delfau-Larue, Wolfram Klapper, Françoise Berger, et al.
British Journal of Haematology
|
August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
Hilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group
Wolfram Klapper, Eva Hoster, Lars Rölver, et al.
Blood Advances
|
April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Diego Villa, Eva Hoster, Olivier Hermine, et al.
Page
of 34